Table 2 Description of 19 patients with confirmed periocular basal cell carcinoma treated with 5% imiquimod cream
Lesion | † Area (mm 2 ) | † Largest diameter (mm) | ‡ Residual area (mm 2 ) | ‡ Largest residual diameter (mm) | Treatment time (weeks) |
|---|---|---|---|---|---|
1 | 131.97 | 12.01 | 13.53 | 4.25 | 8 |
2 | 108.18 | 11.70 | 0 | 0 | 12 |
3 | 64.56 | 10.63 | 0 | 0 | 16 |
4 | 67.09 | 11.65 | 0 | 0 | 12 |
5 | 53.34 | 15.03 | 0 | 0 | 12 |
6 | 20.76 | 5.10 | 0 | 0 | 8 |
7 | 32.32 | 7.51 | 0 | 0 | 10 |
8 | 165.38 | 27.18 | 22.07 | 7.63 | 12 |
9 | 189.14 | 17.96 | 0 | 0 | 12 |
10 | 18.53 | 5.06 | 0 | 0 | 14 |
11 | 15.99 | 2.77 | 0 | 0 | 12 |
12 | 121.01 | 15.66 | 0 | 0 | 16 |
13 | 35.53 | 9.46 | 0 | 0 | 14 |
14 | 45.32 | 16.01 | 0 | 0 | 12 |
15 | 4.36 | 2.82 | 0 | 0 | 12 |
16 | 39.83 | 10.29 | 0 | 0 | 14 |
17 | 121.27 | 15.45 | 0 | 0 | 16 |
18 | 60.63 | 8.70 | 0 | 0 | 16 |
19 | 32.18 | 5.38 | 0 | 0 | 12 |